Organic electroluminescent materials and devices
US-2018013077-A1 · Jan 11, 2018 · US
US11414430B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11414430-B2 |
| Application number | US-201916514854-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 17, 2019 |
| Priority date | Dec 17, 2018 |
| Publication date | Aug 16, 2022 |
| Grant date | Aug 16, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A condensed cyclic compound is represented by Formula 1. An organic light-emitting device includes: a first electrode; a second electrode; and an organic layer between the first electrode and the second electrode and comprising an emission layer, the organic layer including the condensed cyclic compound represented by Formula 1. A display apparatus includes: a thin-film transistor comprising a source electrode, a drain electrode, and an active layer; and the organic light-emitting device.
Opening claim text (preview).
What is claimed is: 1. A condensed cyclic compound represented by Formula 1: (A 11 ) n11 -(L 11 ) a11 -(A 12 ) n12 , Formula 1 wherein, in Formula 1, a11 is an integer of 0 to 5, A 11 and A 12 are each independently selected from a group represented by Formula 1A and a group represented by Formula 1B, and n11 and n12 are each 1: wherein, in Formulae 1A and 1B, X 11 is selected from C(R 14 )(R 15 ), Si(R 14 )(R 15 ), O, and S, X 12 is selected from C(R 16 )(R 17 ), Si(R 16 )(R 17 ), O, and S, b11 is selected from 1 and 2, b12 and b13 are each independently an integer from 1 to 3, Q 1 to Q 3 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, and * indicates a binding site to a neighboring atom, wherein, in Formula 1: L 11 is selected from groups represented by Formulae 4-1 to 4-35; wherein, in Formulae 4-1 to 4-35, X 41 is C(R 43 )(R 44 ), R 41 to R 44 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, and a perylenyl group, b41 is selected from 1, 2, 3, and 4, b42 is selected from 1, 2, 3, 4, 5, and 6, b43 is selected from 1, 2, 3, 4, 5, 6, 7, and 8, b44 is selected from 1, 2, 3, 4, and 5, b45 is selected from 1, 2, and 3, b46 is selected from 1 and 2, and * and *′ each indicate a binding site to a neighboring atom, wherein, in Formula 1: R 11 to R 13 are each hydrogen, R 14 to R 17 are each independently selected from: hydrogen, deuterium, —F, —Cl , —Br, —I, a cyano group, and a C 1 -C 20 alkyl group; a C 1 -C 20 alkyl group substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, and a cyano group; and groups represented by Formulae 5-1 to 5-9: wherein, in Formulae 5-1 to 5-9, R 51 and R 52 are each independently selected from hydrogen, deuterium, —F, —Cl , —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, and a perylenyl group, b51 is selected from 1, 2, 3, 4, and 5, b52 is selected from 1, 2, 3, 4, 5, 6, and 7, b53 is selected from 1, 2, 3, 4, 5, 6, 7, 8, and 9, b54 is selected from 1, 2, 3, and 4, and * indicates a binding site to a neighboring atom. 2. The condensed cyclic compound of claim 1 , wherein: L 11 is selected from groups represented by Formulae 4-1 to 4-12. 3. The condensed cyclic compound of claim 1 , wherein: a11 is selected from 0, 1, and 2. 4. The condensed cyclic compound of claim 1 , wherein: X 11 is C(R 14 )(R 15 ), and X 12 is C(R 16 )(R 17 ). 5. The condensed cyclic compound of claim 1 , wherein: the condensed cyclic compound is represented by one selected from Formulae 1-1 and 1-2: wherein, in Formulae 1-1 and 1-2, L 11 and a11 are each independently the same as defined in connection with Formula 1, X 11a and X 11b are each independently the same as defined in connection with X 11 in Formula 1A, X 12a and X 12b are each independently the same as defined in connection with X 12 in Formula 1A, R 11a , R 11b , R 12a , R 12b , R 13a , and R 13b are each independently the same as defined in connection with R 11 in Formula 1A, b11a and b11b are each independently the same as defined in connection with b11 in Formula 1A, and b12a, b12b, b13a, and b13b are each independently the same as defined in connection with b12 in Formula 1A. 6. The condensed cyclic compound of claim 1 , wherein: the condensed cyclic compound is represented by one selected from Formulae 1-11 and 1-12: wherein, in Formulae 1-11 and 1-12, L 11 is selected from groups represented by Formulae 4-1 to 4-12: wherein, in Formulae 4-1 to 4-12, R 41 is selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, and a perylenyl group, b41 is selected from 1, 2, 3, and 4, b42 is selected from 1, 2, 3, 4, 5, and 6, * and *′ each indicate a binding site to a neighboring atom, a11 is selected from 0, 1, and 2, R 11a , R 11b , R 12a , R 12b , R 13a , R 13b , R 14a , R 14b , R 15a , R 15b , R 16a , R 16b , R 17a , and R 17b are each independently the same as defined in connection with R 11 in Formula 1A, b11a and b11b are each independently the same as defined in connection with b11 in Formula 1A, and b12a, b12b, b13a, and b13b are each independently defined the same as b12 in Formula 1A. 7. The condensed cyclic compound of claim 1 , wherein: the condensed cyclic compound is selected from Compounds 1 to 6:
Organic PV cells · CPC title
Active-matrix OLED [AMOLED] displays · CPC title
Electron blocking layers · CPC title
Carrier blocking layers · CPC title
containing organic luminescent materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.